Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Lexeo Therapeutics, Inc. (LXEO) had Weighted-Average Shares Outstanding (Basic) of 53.65M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-99.96M |
|
-- |
|
-- |
|
$109.26M |
|
$-109.26M |
|
$9.30M |
|
$-99.96M |
|
$-103.35M |
|
$-99.96M |
|
$-99.96M |
|
$-99.96M |
|
$-103.35M |
|
$-109.26M |
|
$-108.88M |
|
|
Weighted-Average Shares Outstanding (Basic) |
53.65M |
53.65M |
|
$-1.86 |
|
$-1.86 |
|
| Balance Sheet Financials | |
$188.39M |
|
$1.14M |
|
$80.30M |
|
$268.69M |
|
$16.81M |
|
$0.33M |
|
$5.21M |
|
$22.02M |
|
$246.67M |
|
$246.67M |
|
$246.67M |
|
73.00M |
|
| Cash Flow Statement Financials | |
$-98.56M |
|
$-90.25M |
|
$216.79M |
|
$38.27M |
|
$66.25M |
|
$27.98M |
|
$12.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.21 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-98.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.52% |
|
-40.52% |
|
-37.20% |
|
-40.47% |
|
$3.38 |
|
$-1.84 |
|
$-1.84 |
|